MAPT and Alzheimer disease: However, higher levels of TREM2 protein have been reported in the middle temporal cortices of late-onset AD patients in their 80s than in age-matched control tissue, and this increase was correlated with that of phosphorylated tau and apoptotic markers (Lue et al., 2015).